Find a Doctor

Anil K. Bhansali

Post Graduate Institute Of Medical Education And Research
Male

Bio


Anil Bhansali is in Chandigarh, India. They have been an author on 413 peer reviewed articles and participated in 4 clinical trials in the past 15 years.

Contact

Chandigarh, CH, IN

Latest Research


Latest Advance
Study
  • Condition: Wolfram Syndrome
  • Journal: Endocrine
  • Treatment Used: Multidisciplinary Approach
  • Number of Patients: 5
  • Published —
This study tested the safety and efficacy of using a multidisciplinary approach with clinical and genetic profiling to treat patients with Wolfram syndrome characterized by primary gonadal failure.
Latest Advance
Study
  • Condition: Co-Occurrence of Craniopharyngioma and IgG4-Related Hypophysitis
  • Journal: World neurosurgery
  • Treatment Used: Pterional Craniotomy and Gross Total Excision
  • Number of Patients: 1
  • Published —
This case report describes a 16-year-old boy diagnosed with craniopharyngioma and secondary hypophysitis (inflamed pituitary gland) treated with pterional craniotomy and gross total excision of the lesion.
Latest Advance
Study
  • Condition: Type 2 Diabetes with Hypertriglyceridemia
  • Journal: Scientific reports
  • Treatment Used: Dual PPAR ?/? agonist (Saroglitazar)
  • Number of Patients: 30
  • Published —
The study researched using Dual PPAR ?/? agonist for type 2 diabetes with hypertriglyceridemia.
Latest Advance
Study
  • Condition: Chronic Myeloid Leukemia in Children
  • Journal: Pediatric hematology and oncology
  • Treatment Used: Growth Hormone Therapy
  • Number of Patients: 20
  • Published —
In this study, researchers evaluated the effects of growth hormone therapy for Imatinib-related growth problems in children with chronic myeloid leukemia.
Latest Advance
Study
  • Condition: Advanced Pheochromocytoma and Paraganglioma (PPGLs)
  • Journal: Clinical endocrinology
  • Treatment Used: Peptide Receptor Radionuclide Therapy (PRRT)
  • Number of Patients: 201
  • Published —
This review of the literature evaluated the effectiveness and safety of peptide receptor radionuclide therapy (PRRT) in patients with advanced pheochromocytomas and paragangliomas (rare tumors; PPGLs).
Latest Advance
Study
  • Condition: Type II Diabetes
  • Journal: BMC pharmacology & toxicology
  • Treatment Used: Linagliptin or Voglibose
  • Number of Patients: 30
  • Published —
This study compared the clinical outcomes of linagliptin and voglibose on glycemic control of patients with Type II Diabetes.

Contact

Chandigarh, CH, IN

Insurance

Contact them to find out if they accept your insurance plan.